Evidence map›Paper›PMID 41225301›Full record

ReviewImmunological reviews2025

Escape From X Chromosome Inactivation as a Driver of Plasmacytoid DC Heterogeneity in Health and Disease.

Franck J Barrat, Jean-Charles Guéry

Abstract readReview
In one paragraph

Review in Immunological reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Franck J BarratInflammation and Autoimmunity Program and David Z. Rosensweig Genomics Research Center, HSS Research Institute, Hospital for Special Surgery, New York, New York, USA.ORCID https://orcid.org/0000-0002-0735-0850
Jean-Charles GuéryUniv Toulouse, INSERM, CNRS, Infinity-Toulouse Institute for Infectious and Inflammatory Diseases, Toulouse, France.

Funding

Role of plasmacytoid dendritic cells in autoimmunityR01AI132447 · NIAID · HOSPITAL FOR SPECIAL SURGERY · PI BARRAT, FRANCK · 2018 to 2022
$2.2M
Agence Nationale de la Recherche ANR-20-CE15-0014-01Agence Nationale de la Recherche ANR-23-CE15-0002-01Fondation pour la Recherche Médicale EQU202403018065Foundation for Research in Rheumatology 2020-041National Scleroderma Foundation 10.13039/100019921NIAID NIH HHS R01 AI132447NovartisRégion Occitanie/Pyrénées-Méditerranée 1901175Scleroderma Research FoundationSociété Française de Rhumatologie (2025)
6 · The paper itself

Abstract

Decades of experimental work have helped define the heterogeneity of the various cell types that compose the immune system. The different cell types arise from distinct hematopoietic stem and progenitor cells in a coordinated fashion during ontogeny, providing a set of diverse cells that contribute to host defense. Cells can also differentiate into different subsets in response to the cytokine and tissue environment, creating a level of cellular heterogeneity that helps direct the nature and magnitude of the immune response. Here we are discussing a variation whereby cellular heterogeneity arises due to the expression of X-linked immune genes that escape X chromosome inactivation, giving an advantage to a subset of cells more prone to respond to stimulation by external (pathogens) but also internal signals (i.e., mechanosensing). Interestingly, these inflammatory subsets are much more likely to be differentially enriched in patients with autoimmunity or inflammatory diseases which are well known to be predominant in females. We are using plasmacytoid dendritic cells (pDCs) as a model cell type, as these cells are a rare but critical subset of innate immune cells, with a rapid and massive capacity to produce type I IFNs (IFN-I) upon sensing of nucleic acids from pathogens, but also from the self, and these cells have been linked to the pathogenesis of many autoimmune diseases.

Indexed as

Autoimmune DiseasesDendritic CellsX Chromosome InactivationAnimalsAutoimmunityHumansImmunity, InnateInterferon Type IInterferon Type Iautoimmunityplasmacytoid DCsTLRsX chromosome inactivation

Identifiers

PMID41225301
PMCPMC12612386

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.